226 related articles for article (PubMed ID: 35519791)
1. Neutrophil-to-Lymphocyte Ratio as a Predictor of Disease Severity and Mortality in Coronavirus Disease 2019: Prospective Study From Central India.
Rathod BD; Amle D; Khot RS; Prathipati KK; Joshi PP
Cureus; 2022 Mar; 14(3):e23696. PubMed ID: 35519791
[TBL] [Abstract][Full Text] [Related]
2. Association of vitamin D with the severity of disease and mortality in COVID-19: Prospective study in central India.
Rathod BD; Ahirwar AK; Banerjee S; Joshi PP; Khot RS; Dube AH; Kumbhalkar SD; Dabhekar SB
Ann Afr Med; 2023; 22(1):117-123. PubMed ID: 36695233
[TBL] [Abstract][Full Text] [Related]
3. Routine hematology parameters in COVID-19: A predictor of disease severity and mortality.
Awale RB; Singh A; Mishra P; Bais PS; Vansh K; Shamim R; Ghatak T; Hashim Z; Gupta D; Nath A; Singh RK; Singh C; Pande S
J Family Med Prim Care; 2022 Jul; 11(7):3423-3429. PubMed ID: 36387722
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio and Their Role as Predictors of Disease Severity of Coronavirus Disease 2019 (COVID-19).
Jain R; Gopal A; Pathak BK; Mohakuda SS; Tilak T; Singh AR
J Lab Physicians; 2021 Mar; 13(1):58-63. PubMed ID: 34103879
[No Abstract] [Full Text] [Related]
5. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
6. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters.
Wang C; Deng R; Gou L; Fu Z; Zhang X; Shao F; Wang G; Fu W; Xiao J; Ding X; Li T; Xiao X; Li C
Ann Transl Med; 2020 May; 8(9):593. PubMed ID: 32566620
[TBL] [Abstract][Full Text] [Related]
7. Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19.
Tufa A; Gebremariam TH; Manyazewal T; Asrat Y; Getinet T; Hundie TG; Webb DL; Hellström PM; Genet S
PLoS One; 2022; 17(10):e0275391. PubMed ID: 36201435
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study.
Singh Y; Singh A; Rudravaram S; Soni KD; Aggarwal R; Patel N; Wig N; Trikha A
Indian J Crit Care Med; 2021 Aug; 25(8):847-852. PubMed ID: 34733022
[No Abstract] [Full Text] [Related]
9. Circulatory Cytokine Levels as a Predictor of Disease Severity in COVID-19: A Study from Western India.
Bhandari S; Rankawat G; Mathur S; Kumar A; Sahlot R; Jain A
J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598128
[TBL] [Abstract][Full Text] [Related]
10. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
Kodavoor Vadiraj P; Thareja S; Raman N; Karantha SC; Jayaraman M; Vardhan V
J Clin Exp Hepatol; 2022; 12(4):1114-1123. PubMed ID: 35125781
[TBL] [Abstract][Full Text] [Related]
11. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
Fei M; Tong F; Tao X; Wang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil to Lymphocyte Ratio (NLR) and Derived NLR Combination: A Cost-effective Predictor of Moderate to Severe COVID-19 Progression.
Ardestani SK; Salehi MR; Attaran B; Hashemi SM; Sadeghi S; Ghaffarpour S; Tuserkani F; Ghazanfari T
Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):241-253. PubMed ID: 35822675
[TBL] [Abstract][Full Text] [Related]
13. Utility of Neutrophil-Lymphocyte Ratio (NLR) as an Indicator of Disease Severity and Prognostic Marker among Patients with Covid-19 Infection in a Tertiary Care Centre in Bangalore - A Retrospective Study.
PrakashRao VV
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443517
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-Lymphocyte Ratio and Cut-off Values as Predictor of Severity and Mortality in COVID-19 Patients in Millennium COVID-19 Care Center, Addis Ababa, Ethiopia.
Tadesse Z; Bekele Bayissa A; Diriba T; Chernet N; Tsegaye S; Tsega M
Int J Gen Med; 2022; 15():6739-6755. PubMed ID: 36039306
[TBL] [Abstract][Full Text] [Related]
15. Does Neutrophil-to-lymphocyte Ratio at Admission Predict Severity and Mortality in COVID-19 Patients? A Systematic Review and Meta-analysis.
Sarkar PG; Pant P; Kumar J; Kumar A
Indian J Crit Care Med; 2022 Mar; 26(3):361-375. PubMed ID: 35519918
[TBL] [Abstract][Full Text] [Related]
16. Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center.
Kumar Gothwal S; Singh VB; Shrivastava M; Banseria R; Goyal K; Singh S; Ali H; Saad Alharbi K; Singh Y; Gupta G
Altern Ther Health Med; 2021 Jun; 27(S1):18-24. PubMed ID: 33609349
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.
Giede-Jeppe A; Reichl J; Sprügel MI; Lücking H; Hoelter P; Eyüpoglu IY; Kuramatsu JB; Huttner HB; Gerner ST
J Neurosurg; 2019 Feb; 132(2):400-407. PubMed ID: 30717052
[TBL] [Abstract][Full Text] [Related]
18. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study.
Sayed AA; Allam AA; Sayed AI; Alraey MA; Joseph MV
Saudi Med J; 2021 Apr; 42(4):370-376. PubMed ID: 33795491
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
[No Abstract] [Full Text] [Related]
20. Sex-Dependent Performance of the Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte and Mean Platelet Volume-to-Platelet Ratios in Discriminating COVID-19 Severity.
Fors M; Ballaz S; Ramírez H; Mora FX; Pulgar-Sánchez M; Chamorro K; Fernández-Moreira E
Front Cardiovasc Med; 2022; 9():822556. PubMed ID: 35463770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
